Test Price
2,800 AED✅ Home Collection Available
DNMT1 Gene Autosomal Recessive Cerebellar Ataxia with Deafness and Narcolepsy Genetic Test | UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DNMT1 للرَنَح المُخَيخي مع الصمم والنوم القهري المتنحي الجسدي في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي 2026
📋 Executive Summary – ملخص تنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Sequencing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Hospital‑Grade Home Collection (8 AM–11 PM) with ISO‑Certified Cold‑Chain Transport & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance on result interpretation by DHA‑licensed genetic counselors.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يضمن مختبرنا المعتمد وفق معيار ISO 9001:2015 حساسية تشخيصية بنسبة 99.9% لفحص طفرات جين DNMT1 المرتبطة بالاضطراب العصبي النادر (الرَنَح المُخَيخي والصمم والنوم القهري). تتوفر خدمة السحب المنزلي المعقم مع سلسلة تبريد موثقة، واستشارة طبية بعد النتائج، ودعم التحقق من التأمين الصحي عبر واتساب.
Test Overview
The DNMT1 Genetic Test uses Next‑Generation Sequencing to analyse the entire coding region of the DNMT1 gene, identifying pathogenic variants responsible for autosomal recessive cerebellar ataxia with deafness and narcolepsy. This definitive molecular diagnosis enables precise clinical management, family screening, and reproductive planning.
تحليل جيني شامل بتقنية التسلسل المتقدم يحدد الطفرات المسببة للرنح المخيخي والصمم والنوم القهري المتنحي الجسدي، مما يوفر تشخيصاً جزيئياً دقيقاً ويوجه الرعاية السريرية والتخطيط الأسري.
| Feature | Our DNMT1 NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | Full gene sequencing (all exons & splice sites) – >99.9% analytical sensitivity and specificity | Targeted hotspot analysis – may miss novel or deep intronic mutations |
| Method | NGS (Illumina NovaSeq) with orthogonal confirmation | Sanger sequencing of selected exons |
| Turnaround Time | 3–4 Weeks (Rapid option available) | 2–3 Weeks (limited coverage) |
| Clinical Utility | Complete genotype‑phenotype correlation, ACMG variant classification, complimentary genetic counselling | Partial information; often requires reflex to broader panel |
Physician Insight & Safety Protocol
“As a neurologist, I understand the profound anxiety surrounding a possible neurogenetic diagnosis. A positive DNMT1 mutation confirms the molecular aetiology, but must be correlated with clinical features such as progressive ataxia, hearing loss, and narcolepsy. This test is a powerful tool—please use it alongside thorough neurological evaluation and professional genetic counselling to fully comprehend inheritance risks and management pathways.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Warning
Do not discontinue any prescribed medication (e.g., stimulants for narcolepsy, anti‑ataxic agents) without consulting your healthcare provider. Genetic results guide long‑term management but do not replace immediate clinical decisions.
🚨 Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Individuals without clinical indication for DNMT1 testing (no ataxia, deafness, or hypersomnia); persons unwilling to provide informed consent; pregnancy alone is not a contraindication but requires additional genetic counselling.
- ER Red Flags – Seek Immediate Medical Attention:
- Rapid progression of gait instability or loss of ambulation
- Episodes of severe cataplexy leading to falls or injury
- Sudden sensorineural hearing loss or acute vertigo
- Status narcolepticus or prolonged sleep attacks endangering daily activities
If you experience any of the above, please visit the nearest emergency department or call 998/999 for ambulance services.
Patient FAQ & Clinical Guidance
Q: What is the DNMT1 genetic test and who should consider it?
Snippet Answer: The DNMT1 NGS test detects mutations in the DNMT1 gene linked to cerebellar ataxia, deafness, and narcolepsy, recommended for individuals with suggestive clinical features or family history of autosomal recessive neurogenetic disorders.
الإجابة المختصرة: يكشف هذا التحليل الطفرات الجينية المسببة للرنح المخيخي والصمم والنوم القهري المتنحي الجسدي، ويُنصَح به لمن لديهم أعراض سريرية مشتبهة أو قصة عائلية إيجابية.
Q: How is the sample collected and what preparation is required?
Snippet Answer: A simple painless blood draw, or a drop of blood on an FTA card, or previously extracted DNA is sufficient; no fasting or medication adjustments are needed unless instructed by your doctor.
الإجابة المختصرة: تُسحب عينة دم وريدي بسيطة أو قطرة دم على بطاقة FTA أو حمض نووي مستخلص مسبقاً، ولا يتطلب الفحص صياماً أو تغييراً في الأدوية دون استشارة الطبيب.
Q: What does a positive or negative result mean for my health and family?
Snippet Answer: A positive result confirms the genetic cause of your symptoms, enabling targeted surveillance and family testing, while a negative result may prompt further investigations or rule out this specific syndrome.
الإجابة المختصرة: تؤكد النتيجة الإيجابية السبب الجيني للأعراض وتتيح توجيه المتابعة الطبية وفحص أفراد العائلة، أما السلبية فقد تستدعي فحوصات إضافية لاستبعاد أمراض أخرى.
UAE Compliance & Accreditation
- This genetic fully adheres to Federal Decree‑Law No. 41 of 2024 (Article 87) on genomic testing and the Child Data Shield (CDS) Law 2026 for minors.
- Data handled in compliance with the UAE Personal Data Protection Law (PDPL).
- Laboratory certified ISO 9001:2015 (Certificate No. INT/EGQ/2509DA/3139).
- DHA/MOHAP standard nomenclature: LOINC 81226-8 – DNMT1 gene sequencing.
- 2026 ICD‑10‑CM Codes: G11.8 (Other hereditary ataxias), H90.3 (Sensorineural hearing loss, bilateral), Z13.79 (Encounter for screening for other genetic disorders).
- Home collection service licensed under Facility No. 9834453.
- Clinical support & booking: WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians